Antibody Testing Market to reach US$ 10,740.69 million by 2027 - Zeus Scientific, Trinity Biotech, Agilent Technologies

Antibodies are immunoglobulins, Y-shaped proteins that are produced by the immune system to help stop intruders from harming the body. An antibody test is a screening for the presence of antibodies in the blood. The body makes antibodies when it fights infection, like COVID-19 or when patients get a vaccine, like a flu shot. That’s how immunity to a virus is built. These tests are also called serology tests.

The scope of the Antibody Testing market includes procedure Antibody Testing products, indication, end user and region. The market for Antibody Testing is analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the Antibody Testing market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.

Download sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00016492/

Company Profiles

• Thermo Fisher Scientific
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Beckton, Dickinson And Company
• F. Hoffmann La Roche
• Agilent Technologies
• DiaSorin
• Zeus Scientific
• Abcam
• Trinity Biotech

Global Antibody Testing Market, based on Antibody Testing Products, the Antibody Testing market is segmented into Kits, Chemical and Reagents, Consumables. In 2019, the Kits segment accounted for the highest share of the market. Growth of this segment is attributed to large number of manufacturers like Abbott, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., and others and higher adoption of kits in various research processes. The same segment is likely to register highest CAGR in the global Antibody Testing market during the forecast period.

Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been urging the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus. Over time, real-time polymerase chain reaction tests and antibody tests have emerged as vital techniques for the global healthcare system to manage the outbreak. Antibody detection is essential for differential diagnosis of SARS-CoV-2. It is a test performed by patient serum or plasma with reagent red cells. Determination of specific antibodies to viral and bacterial pathogens and parasites facilitates the correct therapeutic measures to be taken. Antibody testing is critical for implementing an effective and efficient public health strategy to minimize the adverse impact of the COVID-19 pandemic. It should be adopted for important clinical utility cases and support return-to-work strategy globally.

Antibody detection kits are predictive for prognosis and detection of COVID-19 infections to assist the diseases. Since these kits help examine whether a person has developed antibodies in their bloodstream to fight the SARS-CoV-2, it indicates whether a person has been exposed to or has COVID-19. In order to manage the COVID-19 pandemic and increase patient screening, several companies are offering these rapid antibody detection kits to healthcare workers, hospitals, laboratories, and other professionals. Thus, rising incidence of coronavirus cases and growing government approvals for antibody test kits are the few factors responsible for the growth of the market.

By Product

• Kits,
• Chemical and Reagents,
• Consumables

By Indication      

• Pregnancy,
• Cardiovascular Diseases,
• Autoimmune Diseases,
• Infectious Diseases,
• Oncology,
• Endocrine Diseases,
• Others

By End User

• Hospitals,
• Academic and Research Institutes,
• Diagnostic Laboratories,
• Biopharmaceutical Companies

Purchase a copy of the report @ https://www.theinsightpartners.com/buy/TIPRE00016492/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com